Fennec Pharmaceuticals Inc. FENC
13.33 USD -0.25 (-1.84%)
Regular-session close
13.33 0.00 0.00%
After hours · Nov 18, 4:01 PM ET
13.04 Day range 13.85
5.65 52-week range 13.85
- YTD
- +73.12%
- 1 year
- +52.34%
Benzinga news
benzinga.com HC Wainwright & Co. Maintains Buy on Fennec Pharmaceuticals, Raises Price Target to $17 HC Wainwright & Co. analyst Raghuram Selvaraju maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price target from $16 to $17.
benzinga.com H World Group Posts Upbeat Q3 Earnings, Joins CG Oncology, TELUS And Other Big Stocks Moving Higher On Monday U.S. stocks fell, but H World Group surged 9.3% on strong Q3 results and raised guidance; several other stocks posted notable gains.benzinga.com B. Riley Securities Reiterates Buy on Fennec Pharmaceuticals, Raises Price Target to $19 B. Riley Securities analyst Madison El-Saadi reiterates Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price target from $18 to $19.
benzinga.com Fennec Pharmaceuticals Q3 2026 Earnings Call Transcript Fennec Pharmaceuticals (NASDAQ:FENC) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…benzinga.com Fennec Pharmaceuticals Q3 EPS $0.12 Beats $0.10 Estimate, Sales $19.608M Beat $18.401M Estimate Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.10 by 20 percent. This is a 700 percent increase over losses of…
